These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9280851)

  • 21. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.
    Suzuki K; Awata S; Takano T; Ebina Y; Shindo T; Harada N; Matsuoka H
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):486-92. PubMed ID: 16884452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid improvement of depression and psychotic symptoms in Huntington's disease: a retrospective chart review of seven patients treated with electroconvulsive therapy.
    Cusin C; Franco FB; Fernandez-Robles C; DuBois CM; Welch CA
    Gen Hosp Psychiatry; 2013; 35(6):678.e3-5. PubMed ID: 23541803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetric bilateral right frontotemporal left frontal stimulus electrode placement for electroconvulsive therapy.
    Swartz CM
    Neuropsychobiology; 1994; 29(4):174-8. PubMed ID: 8047243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of the initial stimulus dose in right unilateral and bifrontal electroconvulsive therapy.
    Heikman P; Tuunainen A; Kuoppasalmi K
    Psychol Med; 1999 Nov; 29(6):1417-23. PubMed ID: 10616948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression.
    McCormick LM; Yamada T; Yeh M; Brumm MC; Thatcher RW
    J Psychiatr Res; 2009 Feb; 43(5):553-60. PubMed ID: 18851858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey.
    Özdemir A; Poyraz CA; Erten E; Çırakoğlu E; Tomruk N
    Psychiatr Q; 2016 Dec; 87(4):769-779. PubMed ID: 26887856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical value of electroconvulsive therapy in treatment of depression].
    Frey R; Schreinzer D
    Wien Med Wochenschr; 1999; 149(18):525-31. PubMed ID: 10637958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing patterns of electroconvulsive therapy use: results of a five-year survey.
    Galletly CA; Field CD; Ormond CL
    Aust N Z J Psychiatry; 1991 Dec; 25(4):535-40. PubMed ID: 1793423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ECT and mental retardation: a review and case reports.
    Aziz M; Maixner DF; DeQuardo J; Aldridge A; Tandon R
    J ECT; 2001 Jun; 17(2):149-52. PubMed ID: 11417928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrode placement in ECT: cognitive effects.
    Lawson JS; Inglis J; Delva NJ; Rodenburg M; Waldron JJ; Letemendia FJ
    Psychol Med; 1990 May; 20(2):335-44. PubMed ID: 2356258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Matsuoka H
    J ECT; 2003 Jun; 19(2):73-80. PubMed ID: 12792454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular response to unilateral electroconvulsive therapy.
    Webb MC; Coffey CE; Saunders WR; Cress MM; Weiner RD; Sibert TR
    Biol Psychiatry; 1990 Nov; 28(9):758-66. PubMed ID: 2257285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current status of seizure duration in the practice of electroconvulsive therapy.
    Lalla FR; Milroy T
    Can J Psychiatry; 1996 Jun; 41(5):299-304. PubMed ID: 8793149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals.
    Slade EP; Jahn DR; Regenold WT; Case BG
    JAMA Psychiatry; 2017 Aug; 74(8):798-804. PubMed ID: 28658489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EEG evidence of more "intense" seizure activity with bilateral ECT.
    Krystal AD; Weiner RD; Coffey CE; Smith P; Arias R; Moffett E
    Biol Psychiatry; 1992 Mar; 31(6):617-21. PubMed ID: 1581442
    [No Abstract]   [Full Text] [Related]  

  • 38. Has electroconvulsive therapy use remained stable over time? A decade of electroconvulsive therapy service provision in Victoria, Australia.
    Plakiotis C; George K; O'Connor DW
    Aust N Z J Psychiatry; 2012 Jun; 46(6):522-31. PubMed ID: 22375067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical predictors of short-term outcome in electroconvulsive therapy.
    Lam RW; Bartley S; Yatham LN; Tam EM; Zis AP
    Can J Psychiatry; 1999 Mar; 44(2):158-63. PubMed ID: 10097836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility, safety, and preliminary efficacy of Low Amplitude Seizure Therapy (LAP-ST): A proof of concept clinical trial in man.
    Youssef NA; Sidhom E
    J Affect Disord; 2017 Nov; 222():1-6. PubMed ID: 28667887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.